Return to study ST001990 main page

MB Sample ID: SA186017

Local Sample ID:CatS_Bov3_5
Subject ID:SU002071
Subject Type:Insect
Subject Species:Duponchelia fovealis

Select appropriate tab below to view additional metadata details:


Subject:

Subject ID:SU002071
Subject Type:Insect
Subject Species:Duponchelia fovealis

Factors:

Local Sample IDMB Sample IDFactor Level IDLevel ValueFactor Name
CatS_Bov3_5SA186017FL023009Duponchelia fovealis that survived the application of the Bov 3 strain of Beauveria bassianaFactor

Collection:

Collection ID:CO002064
Collection Summary:Groups of 10 third instar caterpillars were placed on strawberry leaves and sprayed with 1 mL of B. bassiana conidia-suspension: 2 x 107 conidia/mL in 0.85% saline solution with Tween 80® adhesive spreader added. Therefore, the treatments applied were: control caterpillars (consisting only of 0.85% saline solution and Tween 80®), caterpillars inoculated with Bov 3 strain of B. bassiana, caterpillars inoculated with Bov 2 strain of B. bassiana and caterpillars inoculated with the Bov3-Bov 2 consortium. On the seventh day, caterpillars that did not respond to the stimulus provided by the touch of a brush were considered dead. All caterpillars were identified as living or dead at the end of the seven days and were subsequently stored in a freezer at -80ºC.
Collection Protocol Filename:Metabolite_Extraction
Sample Type:Insect tissue
Storage Conditions:-80℃

Treatment:

Treatment ID:TR002083
Treatment Summary:The treatments applied were: control caterpillars (consisting only of 0.85% saline solution and Tween 80®), caterpillars inoculated with Bov 3 strain of B. bassiana, caterpillars inoculated with Bov 2 strain of B. bassiana and caterpillars inoculated with the Bov3-Bov2 consortium.
Treatment Protocol Filename:Metabolite_Extraction
Treatment Dosevolume:2 x 10^7 conidia/mL

Sample Preparation:

Sampleprep ID:SP002077
Sampleprep Summary:After the direct contact bioassay, the caterpillars were arranged by treatment, then macerated in liquid nitrogen (N2). Extraction was performed with 200 mg of the macerate added to a 1 mL microtube (Eppendorf, Germany) previously treated with methanol. Following this, 125 μL of chloroform (CHCl3), 50 μL ultra-pure water (H2O), and 250 μL cold methanol (CH3OH) were added to the macerate. The microtubes were vigorously vortexed and placed in an ultrasonic bath (Odontobrás, Ribeirão-SP) at 20 Hz and approximately 4ºC for 10 minutes. Then, 50 μL of CHCl3 and 50 μL of H2O were added, and the tubes were vortexed again. The samples were centrifuged (Eppendorf, Germany) for 5 minutes at 14000 rpm and 4°C, and the supernatant was filtered on a Whatman® 0.22 µm filter (Merck, Germany) and transferred to a glass vial. The vial was taken to a lyophilizer (Thermo Fischer Scientific, MA) until the samples had completely dried. Finally, the lyophilized samples were resuspended in 200 µL of extraction solution and aliquoted for use in the GC-MS and LC-MS/MS.
Sampleprep Protocol Filename:Metabolite_Extraction
Extract Storage:-80℃

Combined analysis:

Analysis ID AN003242 AN003243 AN003244 AN003245 AN003246 AN003247
Analysis type MS MS MS MS MS MS
Chromatography type GC GC Reversed phase Reversed phase Reversed phase Reversed phase
Chromatography system Agilent 7890A Agilent 7890A Waters Acquity UPLC Waters Acquity UPLC Waters Acquity UPLC Waters Acquity UPLC
Column Agilent DB-5 (20m x 0.18mm, 0.18um); Restek RX-T 17 (0.9m x 0.10mm, 0.10um) Agilent DB-5 (20m x 0.18mm, 0.18um); Restek RX-T 17 (0.9m x 0.10mm, 0.10um) Waters Acquity UPLC HSS (100 x 2.1mm, 1.7um) Waters Acquity UPLC HSS (100 x 2.1mm, 1.7um) Waters Acquity UPLC HSS (100 x 2.1mm, 1.7um) Waters Acquity UPLC HSS (100 x 2.1mm, 1.7um)
MS Type EI API ESI ESI ESI ESI
MS instrument type GC x GC-TOF GC x GC-TOF QTOF QTOF QTOF QTOF
MS instrument name Leco Pegasus 4D GCxGC TOF Leco Pegasus 4D GCxGC TOF Waters Acquity UPLC Waters Acquity UPLC Waters Acquity UPLC Waters Acquity UPLC
Ion Mode UNSPECIFIED UNSPECIFIED NEGATIVE POSITIVE NEGATIVE POSITIVE
Units peak area Relative intensity Relative intensity Relative intensity Relative intensity

Chromatography:

Chromatography ID:CH002391
Methods Filename:Metabolomics_Methods
Instrument Name:Agilent 7890A
Column Name:Agilent DB-5 (20m x 0.18mm, 0.18um); Restek RX-T 17 (0.9m x 0.10mm, 0.10um)
Column Temperature:70 - 320 ºC
Flow Rate:1 mL.min-1
Injection Temperature:280 ºC
Sample Injection:1 uL
Oven Temperature:70°C for 2 min, increasing by 15°C·min-1 until it reached 320°C and then held at this temperature for 4 min.
Chromatography Type:GC
  
Chromatography ID:CH002392
Methods Filename:Metabolomics_Methods
Instrument Name:Waters Acquity UPLC
Column Name:Waters Acquity UPLC HSS (100 x 2.1mm, 1.7um)
Column Temperature:35 ºC
Flow Gradient:95% solvent A and 5% B. The gradient increased linearly to 75% A and 25% B over the next 6 min. The polarity was reversed to 25% A and 75% B for 6 min, and finally 5% A and 95% B for 1 min
Flow Rate:0.5 mL·min-1
Solvent A:Water; formic acid
Solvent B:100% acetonitrile; formic acid.
Capillary Voltage:3 kV
Chromatography Type:Reversed phase

MS:

MS ID:MS003015
Analysis ID:AN003242
Instrument Name:Leco Pegasus 4D GCxGC TOF
Instrument Type:GC x GC-TOF
MS Type:EI
MS Comments:Data from GC-MS was processed using ChromaTOF 4.32 software to conduct baseline correction, deconvolution, retention index (RI), retention time correction (RT), identification, and alignment of peaks. NIST library version 11 was used for the identification of metabolites. Only metabolites with a score of 700 or above were considered. The intensity of each metabolite was normalized by the total ion count (TIC) of each sample. Statistical analyses were performed using the MetaboAnalyst 4.0 online software (available at http://www.metaboanalyst.ca/MetaboAnalyst/)
Ion Mode:UNSPECIFIED
Fragmentation Method:EI
Ion Source Temperature:250 ºC
Ionization Energy:70 eV
Analysis Protocol File:metabolomics_methods.pdf
  
MS ID:MS003016
Analysis ID:AN003243
Instrument Name:Leco Pegasus 4D GCxGC TOF
Instrument Type:GC x GC-TOF
MS Type:API
MS Comments:Data from GC-MS was processed using ChromaTOF 4.32 software to conduct baseline correction, deconvolution, retention index (RI), retention time correction (RT), identification, and alignment of peaks. NIST library version 11 was used for the identification of metabolites. Only metabolites with a score of 700 or above were considered. The intensity of each metabolite was normalized by the total ion count (TIC) of each sample. Statistical analyses were performed using the MetaboAnalyst 4.0 online software (available at http://www.metaboanalyst.ca/MetaboAnalyst/)
Ion Mode:UNSPECIFIED
Fragmentation Method:EI
Ion Source Temperature:250 ºC
Ionization Energy:70 eV
Analysis Protocol File:metabolomics_methods.pdf
  
MS ID:MS003017
Analysis ID:AN003244
Instrument Name:Waters Acquity UPLC
Instrument Type:QTOF
MS Type:ESI
MS Comments:Generated data were pre-processed using MassLynx 4.1 software (Waters Corporation, MA, USA) and then analyzed using MetaboAnalyst 4.0 online software. Fragmentation was performed under the same conditions as the ionization source, using collision energies between 15 and 50 eV. The search for metabolites was performed in the Human Metabolome Database (HMDB) using a mass tolerance of up to 0.1 Da and considering the adduct of [M-H]-. The structures of the molecules were imported and underwent in silico fragmentation using ACD/MS Structure ID software suite (ACD/labs, Toronto, Canada). The fragmentation profile of each molecule proposed by the program was then compared to the fragments generated by MS/MS to accept or reject the identification of metabolites according to similarity.
Ion Mode:NEGATIVE
Capillary Voltage:3 kV
Dry Gas Flow:50 L/hr
Source Temperature:150 ºC
Desolvation Gas Flow:550 L/hr.
Analysis Protocol File:metabolomics_methods.pdf
  
MS ID:MS003018
Analysis ID:AN003245
Instrument Name:Waters Acquity UPLC
Instrument Type:QTOF
MS Type:ESI
MS Comments:Generated data were pre-processed using MassLynx 4.1 software (Waters Corporation, MA, USA) and then analyzed using MetaboAnalyst 4.0 online software. Fragmentation was performed under the same conditions as the ionization source, using collision energies between 15 and 50 eV. The search for metabolites was performed in the Human Metabolome Database (HMDB) using a mass tolerance of up to 0.1 Da and considering the adduct of [M-H]-. The structures of the molecules were imported and underwent in silico fragmentation using ACD/MS Structure ID software suite (ACD/labs, Toronto, Canada). The fragmentation profile of each molecule proposed by the program was then compared to the fragments generated by MS/MS to accept or reject the identification of metabolites according to similarity.
Ion Mode:POSITIVE
Capillary Voltage:3 kV
Dry Gas Flow:50 L/hr
Source Temperature:150 ºC
Desolvation Gas Flow:550 L/hr
Analysis Protocol File:metabolomics_methods.pdf
  
MS ID:MS003019
Analysis ID:AN003246
Instrument Name:Waters Acquity UPLC
Instrument Type:QTOF
MS Type:ESI
MS Comments:Generated data were pre-processed using MassLynx 4.1 software (Waters Corporation, MA, USA) and then analyzed using MetaboAnalyst 4.0 online software. Fragmentation was performed under the same conditions as the ionization source, using collision energies between 15 and 50 eV. The search for metabolites was performed in the Human Metabolome Database (HMDB) using a mass tolerance of up to 0.1 Da and considering the adduct of [M-H]-. The structures of the molecules were imported and underwent in silico fragmentation using ACD/MS Structure ID software suite (ACD/labs, Toronto, Canada). The fragmentation profile of each molecule proposed by the program was then compared to the fragments generated by MS/MS to accept or reject the identification of metabolites according to similarity.
Ion Mode:NEGATIVE
Capillary Voltage:3 kV
Dry Gas Flow:50 L/hr
Source Temperature:150 ºC
Desolvation Gas Flow:550 L/hr
Analysis Protocol File:metabolomics_methods.pdf
  
MS ID:MS003020
Analysis ID:AN003247
Instrument Name:Waters Acquity UPLC
Instrument Type:QTOF
MS Type:ESI
MS Comments:Generated data were pre-processed using MassLynx 4.1 software (Waters Corporation, MA, USA) and then analyzed using MetaboAnalyst 4.0 online software. Fragmentation was performed under the same conditions as the ionization source, using collision energies between 15 and 50 eV. The search for metabolites was performed in the Human Metabolome Database (HMDB) using a mass tolerance of up to 0.1 Da and considering the adduct of [M-H]-. The structures of the molecules were imported and underwent in silico fragmentation using ACD/MS Structure ID software suite (ACD/labs, Toronto, Canada). The fragmentation profile of each molecule proposed by the program was then compared to the fragments generated by MS/MS to accept or reject the identification of metabolites according to similarity.
Ion Mode:POSITIVE
Capillary Voltage:3 kV
Dry Gas Flow:50 L/hr
Source Temperature:150 ºC
Desolvation Gas Flow:550 L/hr
Analysis Protocol File:metabolomics_methods.pdf
  logo